Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
JNJ | NYSE | USD | Real-time | |
JNJ | Mexico | MXN | Delayed | |
1JNJ | Milan | EUR | Real-time | |
JNJ | TradeGate | EUR | Delayed | |
JNJ | Xetra | EUR | Delayed | |
JNJ | Frankfurt | EUR | Delayed | |
DJNJ2 | Buenos Aires | ARS | Delayed | |
JNJ | Buenos Aires | ARS | Delayed | |
JNJB34 | B3 | BRL | Delayed | |
JNJ | Vienna | EUR | Real-time | |
JNJ | Ukraine | UAH | Delayed | |
JNJ_KZ | KASE | USD | Delayed | |
JNJ_KZTQKD | KASE | USD | Delayed | |
JNJ | Colombia | COP | Delayed | |
JNJ | Lima | USD | Delayed |
For the nine months ended 02 October 2016, Johnson & Johnson revenues increased 3% to $53.78B. Net income increased 4% to $12.73B. Revenues reflect Pharmaceutical segment increase of 8% to $25.23B, Western Hemisphere, excluding U.S. segment increase from $1.46B to $4.27B, United States segment increase of 7% to $28.27B. Net income benefited from Selling, marketing and administrative ex decrease of 4% to $14.64B (expense).
Period Ending: | Jun 29, 2015 | Mar 29, 2015 | Dec 28, 2014 | Sep 28, 2014 |
---|---|---|---|---|
Total Revenue | 17787 | 17374 | 18254 | 18467 |
Gross Profit | 12430 | 12092 | 12401 | 13068 |
Operating Income | 5741 | 5575 | 2703 | 6810 |
Net Income | 4516 | 4320 | 2521 | 4749 |
Period Ending: | Jun 29, 2015 | Mar 29, 2015 | Dec 28, 2014 | Sep 28, 2014 |
---|---|---|---|---|
Total Assets | 128590 | 131119 | 132097 | |
Total Liabilities | 60712 | 61367 | 55506 | |
Total Equity | 67878 | 69752 | 76591 |
Period Ending: | Jun 29, 2015 | Mar 29, 2015 | Dec 28, 2014 | Sep 28, 2014 |
---|---|---|---|---|
Period Length: | 0 Months | 3 Months | 12 Months | 9 Months |
Cash From Operating Activities | 2872 | 18471 | 14106 | |
Cash From Investing Activities | -1789 | -12305 | -9383 | |
Cash From Financing Activities | -3227 | -12260 | -11641 | |
Net Change in Cash | -2535 | -6404 | -7109 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review